On ECHEMI
Home > Drugs > Multiple sclerosis
Multiple sclerosis
Multiple sclerosis (MS) is an autoimmune disease characterized by demyelinating lesions in the white matter of the central nervous system (CNS). It occurs in genetically susceptible individuals and environmental factors. MS is the most common and major demyelinating disease of the central nervous system. It is more common in young and middle-aged people. The clinical characteristics are widespread lesions, and there are often remissions and relapses in the course of the disease. Brain, spinal cord and optic nerve damage.
  • Site of disease:

    Cranio-spinal cord
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    White matter degeneration Pathological laughter and crying Slow reaction Convulsions Limb weakness
  • Concurrent disease:

Related Drugs
PREDNISONE- prednisone_tablet
Indication: Prednisone Tablets, USP are indicated in the following conditions: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance) 2. Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: 3. Collagen Diseases During an exacerbation or as maintenance therapy in selected cases of: 4. Dermatologic Diseases 5. Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment: Seasonal or perennial allergic rhinitis 6. Ophthalmic Diseases Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as: Allergic corneal marginal ulcers 7. Respiratory Diseases Symptomatic sarcoidosis 8. Hematologic Disorders Idiopathic thrombocytopenic purpura in adults 9. Neoplastic Diseases For palliative management of: Leukemias and lymphomas in adults 10. Edematous States To induce a diuresis or remission of proteinuria in the nephrotic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus 11. Gastrointestinal Diseases To tide the patient over a critical period of the disease in: Ulcerative colitis 12. Nervous System Acute exacerbations of multiple sclerosis 13. Miscellaneous Tuberculous meningitis with subarachnoid block or, impending block when used concurrently with appropriate antituberculous chemotherapy
Manufacturer:

REMEDYREPACK INC.

PREDNISONE- prednisone_tablet
Indication: INDICATIONS AND USAGE
Prednisone tablets are indicated in the following conditions: 2. Rheumatic Disorders 3. Collagen Diseases Acute rheumatic carditis 4. Dermatologic Diseases 5. Allergic States 6. Ophthalmic Diseases 7. Respiratory Diseases 8. Hematologic Disorders 9. Neoplastic Diseases 10. Edematous States 11. Gastrointestinal Diseases 12. Nervous System 13. Miscellaneous
Multiple Sclerosis
In the treatment of acute exacerbations of multiple sclerosis daily doses of 200 mg of prednisolone for a week followed by 80 mg every other day for 1 month have been shown to be effective. (Dosage range is the same for prednisone and prednisolone.)
Manufacturer:

St. Mary's Medical Park Pharmacy

PREDNISONE- prednisone_tablet
Indication: INDICATIONS AND USAGE
Prednisone tablets are indicated in the following conditions: 2. Rheumatic Disorders 3. Collagen Diseases Acute rheumatic carditis 4. Dermatologic Diseases 5. Allergic States 6. Ophthalmic Diseases 7. Respiratory Diseases 8. Hematologic Disorders 9. Neoplastic Diseases 10. Edematous States 11. Gastrointestinal Diseases 12. Nervous System 13. Miscellaneous
Multiple Sclerosis
In the treatment of acute exacerbations of multiple sclerosis daily doses of 200 mg of prednisolone for a week followed by 80 mg every other day for 1 month have been shown to be effective. (Dosage range is the same for prednisone and prednisolone.)
Manufacturer:

St. Mary's Medical Park Pharmacy

PREDNISONE- prednisone_tablet
Indication: Prednisone Tablets, USP are indicated in the following conditions: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance) 2. Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: 3. Collagen Diseases During an exacerbation or as maintenance therapy in selected cases of: 4. Dermatologic Diseases 5. Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment: Seasonal or perennial allergic rhinitis 6. Ophthalmic Diseases Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as: Allergic corneal marginal ulcers 7. Respiratory Diseases Symptomatic sarcoidosis 8. Hematologic Disorders Idiopathic thrombocytopenic purpura in adults 9. Neoplastic Diseases For palliative management of: Leukemias and lymphomas in adults 10. Edematous States To induce a diuresis or remission of proteinuria in the nephrotic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus 11. Gastrointestinal Diseases To tide the patient over a critical period of the disease in: Ulcerative colitis 12. Nervous System Acute exacerbations of multiple sclerosis 13. Miscellaneous Tuberculous meningitis with subarachnoid block or, impending block when used concurrently with appropriate antituberculous chemotherapy
Manufacturer:

REMEDYREPACK INC.

PREDNISONE- prednisone_tablet
Indication: INDICATIONS AND USAGE
Prednisone tablets are indicated in the following conditions: 1. Endocrine Disorders 2. Rheumatic Disorders 3. Collagen Diseases 4. Dermatologic Diseases 5. Allergic States 6. Ophthalmic Diseases 7. Respiratory Diseases 8. Hematologic Disorders 9. Neoplastic Diseases 10. Edematous States 11. Gastrointestinal Diseases 12. Nervous System 13. Miscellaneous
Multiple Sclerosis
In the treatment of acute exacerbations of multiple sclerosis daily doses of 200 mg of prednisolone for a week followed by 80 mg every other day for 1 month have been shown to be effective. (Dosage range is the same for prednisone and prednisolone.)
Manufacturer:

Proficient Rx LP

BACLOFEN- baclofen_tablet
Indication: Baclofen tablets USP are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. Baclofen tablets USP may also be of some value in patients with spinal cord injuries and other spinal cord diseases. Baclofen tablets USP are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. The efficacy of baclofen in stroke, cerebral palsy, and Parkinson's disease has not been established and, therefore, it is not recommended for these conditions.
Manufacturer:

American Health Packaging

BACLOFEN- baclofen_tablet
Indication: Baclofen tablets USP are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. Baclofen tablets USP may also be of some value in patients with spinal cord injuries and other spinal cord diseases. Baclofen tablets USP are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. The efficacy of baclofen in stroke, cerebral palsy, and Parkinson’s disease has not been established and, therefore, it is not recommended for these conditions.
Manufacturer:

REMEDYREPACK INC.

PREDNISONE- prednisone_tablet
Indication: INDICATIONS AND USAGE
Prednisone Tablets, USP are indicated in the following conditions: Endocrine Disorders Rheumatic Disorders Collagen Diseases Dermatologic Diseases Allergic States Ophthalmic Diseases Respiratory Diseases Hematologic Disorders Neoplastic Diseases Edematous States Gastrointestinal Diseases Miscellaneous
Multiple Sclerosis
In the treatment of acute exacerbations of multiple sclerosis daily doses of 200 mg of prednisolone for a week followed by 80 mg every other day for 1 month have been shown to be effective. (Dosage range is the same for prednisone and prednisolone.)
Manufacturer:

Proficient Rx LP

BACLOFEN- baclofen_tablet
Indication: Baclofen tablets are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Patients should have reversible spasticity so that baclofen tablets treatment will aid in restoring residual function. Baclofen tablets may also be of some value in patients with spinal cord injuries and other spinal cord diseases. Baclofen tablets are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. The efficacy of baclofen in stroke, cerebral palsy, and Parkinson’s disease has not been established and, therefore, it is not recommended for these conditions.
Manufacturer:

REMEDYREPACK INC.

BACLOFEN- baclofen_tablet
Indication: Baclofen tablets are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Patients should have reversible spasticity so that baclofen tablets treatment will aid in restoring residual function. Baclofen tablets may also be of some value in patients with spinal cord injuries and other spinal cord diseases. Baclofen tablets are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. The efficacy of baclofen tablets in stroke, cerebral palsy, and Parkinson's disease has not been established and, therefore, it is not recommended for these conditions.
Manufacturer:

REMEDYREPACK INC.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.